BCL2 and neoplasm: The activated receptors bind to estrogen response elements (EREs) in the promoter regions of target genes and lead to the increased expression of genes regulating cell cycle progression, such as cyclin D1 and c‐Myc, as well as anti‐apoptotic factors like Bcl‐2, thereby promoting sustained tumor growth.